Literature DB >> 8136773

Increased urinary dopamine excretion in young patients with essential hypertension.

I Saito1, S Itsuji, E Takeshita, H Kawabe, M Nishino, H Wainai, C Hasegawa, T Saruta, S Nagano, T Sekihara.   

Abstract

The evidence that some older patients with essential hypertension have low urinary dopamine excretion has brought into question the levels of urinary dopamine and plasma dopa, the major source of urinary dopamine, in young patients with essential hypertension. Twenty-four-hour urine sodium, creatinine, dopamine and noradrenaline and plasma dopa were evaluated in 48 patients with essential hypertension aged 18 to 27 years and 25 normotensive subjects. In comparison with age-matched normotensive subjects, the hypertensive patients had higher urinary dopamine (1920 +/- 80 vs 1520 +/- 130 nmol/day, p < 0.01) and noradrenaline (216 +/- 11 vs 179 +/- 12 nmol/day, p < 0.05) excretion. There was a significant correlation between urinary dopamine and noradrenaline excretion. There was no difference in plasma dopa levels between normotensive and hypertensive subjects. These results suggest that the elevated conversion of dopa to dopamine in the kidney is leading to increased urinary dopamine excretion in young patients with essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8136773     DOI: 10.3109/10641969409068582

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  7 in total

Review 1.  Potential dopamine-1 receptor stimulation in hypertension management.

Authors:  Mohammad Asghar; Seyed K Tayebati; Mustafa F Lokhandwala; Tahir Hussain
Journal:  Curr Hypertens Rep       Date:  2011-08       Impact factor: 5.369

Review 2.  Dopamine receptors: important antihypertensive counterbalance against hypertensive factors.

Authors:  Chunyu Zeng; Pedro A Jose
Journal:  Hypertension       Date:  2010-11-22       Impact factor: 10.190

3.  Dopamine D3 receptor-mediated inhibition of Na+/H+ exchanger activity in normotensive and spontaneously hypertensive rat proximal tubular epithelial cells.

Authors:  Rui Pedrosa; Pedro Gomes; Chunyu Zeng; Ulrich Hopfer; Pedro A Jose; Patrício Soares-da-Silva
Journal:  Br J Pharmacol       Date:  2004-07-20       Impact factor: 8.739

4.  Renalase regulates renal dopamine and phosphate metabolism.

Authors:  Daria Sizova; Heino Velazquez; Benedita Sampaio-Maia; Janete Quelhas-Santos; Manuel Pestana; Gary V Desir
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-17

5.  Upregulation of renal D5 dopamine receptor ameliorates the hypertension in D3 dopamine receptor-deficient mice.

Authors:  Xiaoyan Wang; Crisanto S Escano; Laureano Asico; John E Jones; Alan Barte; Yuen-Sum Lau; Pedro A Jose; Ines Armando
Journal:  Hypertension       Date:  2013-06-10       Impact factor: 10.190

Review 6.  Renal Dopamine Receptors and Oxidative Stress: Role in Hypertension.

Authors:  Jian Yang; Van Anthony M Villar; Pedro A Jose; Chunyu Zeng
Journal:  Antioxid Redox Signal       Date:  2020-05-29       Impact factor: 8.401

7.  Unique role of NADPH oxidase 5 in oxidative stress in human renal proximal tubule cells.

Authors:  Peiying Yu; Weixing Han; Van Anthony M Villar; Yu Yang; Quansheng Lu; Hewang Lee; Fengmin Li; Mark T Quinn; John J Gildea; Robin A Felder; Pedro A Jose
Journal:  Redox Biol       Date:  2014-02-22       Impact factor: 11.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.